Iron chelation excludes protein synthesis inhibition in the tetracycline management of African trypanosomosis

  • Justine T Ekanem Department of Biochemistry, University of Ilorin, Ilorin, Nigeria.
  • Titilayo O Johnson Department of Biochemistry, University of Ilorin, Ilorin, Nigeria.
  • Iyabo S Adenira Department of Biochemistry, University of Ilorin, Ilorin, Nigeria.
  • Valeelat Okeola Department of Biochemistry, University of Ilorin, Ilorin, Nigeria.
Keywords: Tetracycline, iron chelation, T. brucei, growth inhibition

Abstract

Ribonucleotide reductase, an iron requiring enzyme necessary in the production of deoxyribonucleotides required for replication in cell division and proliferation is induced during the S phase of the cell cycle. We have compared the trypanocidal properties of four antibiotics that show bactericidal activities by destabilizing ribosome-mRNA complex to inhibit protein synthesis. Tetracycline and oxytetracycline that have iron chelating properties extended the lifespan of trypanosome infected rats from 6 and 5 days of control to 15 and 12 days respectively while chloramphenicol and streptomycin that have no iron chelating properties could not extend the lifespan of infected rats. We confirm our earlier report that iron chelation plays a prominent role in the tetracycline management of African trypanosomosis.
Key Words: Tetracycline, iron chelation, T. brucei, growth inhibition
Biokemistri Vol.16(2) 2004: 56-63
Published
2005-03-15
Section
Articles

Journal Identifiers


eISSN: 0795-8080